PLK1 and melanoma: Knockout and gene silencing of RSK family members had an overall minimal or insignificant effect on the proliferation of melanoma cell lines, whereas the targeting of PLK1 had a dramatic effect, followed by the targeting of Aurora B, FAK, and CDK2 (Figs 1B and S1A).